TANNENBAUM RENEE P
SEC insider (Form 3/4/5 filer). CIK 0001543174. Director at Cardiff Oncology, Inc. (CRDF) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in PRINCETON, NJ.
Companies TANNENBAUM RENEE P has filed insider reports for
- Cardiff Oncology, Inc. (CRDF): Director
- ANI PHARMACEUTICALS INC (ANIP): Director
TANNENBAUM RENEE P
CIK: 0001543174
Transaction Breakdown
Open Market Buys (P)1 (16.7%)
High conviction signal
Open Market Sales (S)1 (16.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 11, 2026CRDF
Cardiff Oncology, Inc.
AwardDirectStock Options
40.6K shares- - May 21, 2026ANIP
ANI PHARMACEUTICALS INC
AwardDirect4.4K shares- - Dec 5, 2025ANIP
ANI PHARMACEUTICALS INC
SaleDirect1.8K shares at avg. $81.15$146K - Jun 26, 2025CRDF
Cardiff Oncology, Inc.
AwardDirectStock Options
40.6K shares- - May 22, 2025ANIP
ANI PHARMACEUTICALS INC
AwardDirect4.3K shares- - Dec 12, 2024CRDF
Cardiff Oncology, Inc.
PurchaseDirect10K shares at avg. $3.42$34K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  CRDF Cardiff Oncology, Inc. | Award Stock Options | 40,565 | - | - | Direct |
| May 21, 2026 |  ANIP ANI PHARMACEUTICALS INC | Award | 4,357 | - | $0 | Direct |
| Dec 5, 2025 | ANIP ANI PHARMACEUTICALS INC | Sale | 1,800 | $81.15 | $146,070 | Direct |
| Jun 26, 2025 | CRDF Cardiff Oncology, Inc. | Award Stock Options | 40,565 | - | - | Direct |
| May 22, 2025 | ANIP ANI PHARMACEUTICALS INC | Award | 4,336 | - | - | Direct |
| Dec 12, 2024 | CRDF Cardiff Oncology, Inc. | Purchase | 10,000 | $3.42 | $34,224 | Direct |
1-6 of 6 transactions